Revive BioShield II: Bring Big Pharma Back Into Medical Countermeasures

The legislative architect of BioShield II proposal that failed to make it into law in 2005 argues that the proposal remains the best approach for bringing experienced, well-funded medical product companies into the effort to protect the nation against bioterror attacks -- from other governments and from nature.